Healthcare
Live Price
Offline$400.00
-57.46% today
Window Change
-50.06%
Window
Jun 23, 2025 → Mar 18, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 186 bars · Jun 23, 2025 → Mar 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) is a Healthcare stock with a market cap of $814.59B. The stock last traded around $400.00 and down 50.1% across the available one-year price window (Jun 23, 2025 → Mar 18, 2026). Baseline metrics include revenue growth of -0.2%, EPS growth of +178.5%, a dividend yield of 4.4%. What stands out right now is revenue -0.2%, EPS +178.5%, free cash flow -7.9% with operating margin 25.7% and ROIC 13.5%. The dividend matters to the case here, with a current yield around 4.4%. Valuation is more restrained than many high-expectation growth names at P/E 16.0 and price/sales 2.4. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines BMYMP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BMYMP
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BMYMP Max Drawdown
-61.90%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BMYMP and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
-0.2%
EPS Growth
+178.5%
Gross Margin
68.7%
Net Margin
15.0%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.